104 related articles for article (PubMed ID: 28484166)
1. Paroxysmal nocturnal hemoglobinuria from bench to bedside.
Pu JJ; Brodsky RA
Clin Transl Sci; 2011 Jun; 4(3):219-24. PubMed ID: 21707954
[TBL] [Abstract][Full Text] [Related]
2. Case report: Immune pressure on hematopoietic stem cells can drastically expand glycosylphosphatidylinositol-deficient clones in paroxysmal nocturnal hemoglobinuria.
Shingai N; Mizumaki H; Najima Y; Yamada Y; Tran DC; Haraguchi K; Toya T; Okuyama Y; Doki N; Nannya Y; Ogawa S; Nakao S
Front Immunol; 2023; 14():1329403. PubMed ID: 38288112
[TBL] [Abstract][Full Text] [Related]
3. Increased soluble urokinase plasminogen activator receptor (suPAR) is associated with thrombosis and inhibition of plasmin generation in paroxysmal nocturnal hemoglobinuria (PNH) patients.
Sloand EM; Pfannes L; Scheinberg P; More K; Wu CO; Horne M; Young NS
Exp Hematol; 2008 Dec; 36(12):1616-24. PubMed ID: 18954937
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the impact of two C5 genetic variants on C5-eculizumab complex stability at the molecular level.
Peixoto VP; Prudêncio C; Vieira M; Sousa SF
J Biomol Struct Dyn; 2024 Mar; ():1-10. PubMed ID: 38529903
[TBL] [Abstract][Full Text] [Related]
5. PNH and complement gene variants.
Risitano AM
Blood; 2023 Apr; 141(15):1780-1782. PubMed ID: 37052944
[No Abstract] [Full Text] [Related]
6. Paroxysmal nocturnal haemoglobinuria.
Hill A; DeZern AE; Kinoshita T; Brodsky RA
Nat Rev Dis Primers; 2017 May; 3():17028. PubMed ID: 28516949
[TBL] [Abstract][Full Text] [Related]
7. Catastrophic antiphospholipid syndrome: an update.
Espinosa G; Rodríguez-Pintó I; Cervera R
Panminerva Med; 2017 Sep; 59(3):254-268. PubMed ID: 28488841
[TBL] [Abstract][Full Text] [Related]
8. T Cell Transcriptomes from Paroxysmal Nocturnal Hemoglobinuria Patients Reveal Novel Signaling Pathways.
Hosokawa K; Kajigaya S; Keyvanfar K; Qiao W; Xie Y; Townsley DM; Feng X; Young NS
J Immunol; 2017 Jul; 199(2):477-488. PubMed ID: 28630090
[TBL] [Abstract][Full Text] [Related]
9. Standardized high-sensitivity flow cytometry testing for paroxysmal nocturnal hemoglobinuria in children with acquired bone marrow failure disorders: A single center US study.
Donohue RE; Marcogliese AN; Sasa GS; Elghetany MT; Redkar AA; Bertuch AA; Curry CV
Cytometry B Clin Cytom; 2018 Jul; 94(4):699-704. PubMed ID: 28574201
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic use of eculizumab during surgery in chronic cold agglutinin disease.
Tjønnfjord E; Vengen ØA; Berentsen S; Tjønnfjord GE
BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28487302
[TBL] [Abstract][Full Text] [Related]
11. Anti-complement Treatment for Paroxysmal Nocturnal Hemoglobinuria: Time for Proximal Complement Inhibition? A Position Paper From the SAAWP of the EBMT.
Risitano AM; Marotta S; Ricci P; Marano L; Frieri C; Cacace F; Sica M; Kulasekararaj A; Calado RT; Scheinberg P; Notaro R; Peffault de Latour R
Front Immunol; 2019; 10():1157. PubMed ID: 31258525
[TBL] [Abstract][Full Text] [Related]
12. A Pig-a conditional knock-out mice model mediated by Vav-iCre: stable GPI-deficient and mild hemolysis.
Chen Y; Liu H; Zeng L; Li L; Lu D; Liu Z; Fu R
Exp Hematol Oncol; 2022 Jan; 11(1):1. PubMed ID: 35033195
[TBL] [Abstract][Full Text] [Related]
13. Clinical observation of low-dose combination chemotherapy in refractory/recurrent paroxysmal nocturnal hemoglobinuria patients: A single-center retrospective analysis.
Li L; Liu H; Wang H; Liu Z; Chen Y; Liu C; Zhao X; Li L; Wang H; Shao Z; Fu R
J Clin Lab Anal; 2022 Feb; 36(2):e24239. PubMed ID: 35028973
[TBL] [Abstract][Full Text] [Related]
14. CNS glycosylphosphatidylinositol deficiency results in delayed white matter development, ataxia and premature death in a novel mouse model.
Lukacs M; Blizzard LE; Stottmann RW
Hum Mol Genet; 2020 May; 29(7):1205-1217. PubMed ID: 32179897
[TBL] [Abstract][Full Text] [Related]
15. [Molecular genetics, biochemistry, and biology of PNH].
Kinoshita T
Rinsho Ketsueki; 2017; 58(4):353-362. PubMed ID: 28484166
[TBL] [Abstract][Full Text] [Related]
16. [Pathogenesis of paroxysmal nocturnal hemoglobinuria].
Murakami Y
Rinsho Ketsueki; 2016; 57(10):1900-1907. PubMed ID: 27725586
[TBL] [Abstract][Full Text] [Related]
17. Paroxysmal nocturnal hemoglobinuria and the complement system: recent insights and novel anticomplement strategies.
Risitano AM
Adv Exp Med Biol; 2013; 735():155-72. PubMed ID: 23402025
[TBL] [Abstract][Full Text] [Related]
18. [Paroxysmal nocturnal hemoglobinuria and thrombosis in the era of eculizumab].
Nishimura JI
Rinsho Ketsueki; 2018; 59(8):1042-1047. PubMed ID: 30185704
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
